340 related articles for article (PubMed ID: 25302816)
1. Methotrexate-related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis.
Horie N; Kawano R; Kaneko T; Shimoyama T
Aust Dent J; 2015 Sep; 60(3):408-11. PubMed ID: 25302816
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
[TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication.
Hoshida Y; Xu JX; Fujita S; Nakamichi I; Ikeda J; Tomita Y; Nakatsuka S; Tamaru J; Iizuka A; Takeuchi T; Aozasa K
J Rheumatol; 2007 Feb; 34(2):322-31. PubMed ID: 17117491
[TBL] [Abstract][Full Text] [Related]
4. [Methotrexate-associated lymphoproliferative disorder presenting as oral ulcers in a patient with rheumatoid arthritis].
Pastor-Nieto MA; Kilmurray LG; López-Chumillas A; O'Valle F; García-Del Moral R; Puig AM; Bautista P
Actas Dermosifiliogr; 2009 Mar; 100(2):142-6. PubMed ID: 19445880
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.
Yamada K; Oshiro Y; Okamura S; Fujisaki T; Kondo S; Nakayama Y; Suematsu E; Tamura K; Takeshita M
Histopathology; 2015 Jul; 67(1):70-80. PubMed ID: 25429725
[TBL] [Abstract][Full Text] [Related]
6. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
[TBL] [Abstract][Full Text] [Related]
8. EBV-positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases.
Satou A; Banno S; Hanamura I; Takahashi E; Takahara T; Nobata H; Katsuno T; Takami A; Ito Y; Ueda R; Nakamura S; Tsuzuki T
Pathol Int; 2019 Jan; 69(1):21-28. PubMed ID: 30615240
[TBL] [Abstract][Full Text] [Related]
9. Primary Adrenal Lymphoma Possibly Associated With Epstein-Barr Virus Reactivation Due to Immunosuppression Under Methotrexate Therapy.
Ohkura Y; Shindoh J; Haruta S; Kaji D; Ota Y; Fujii T; Hashimoto M; Watanabe G; Matsuda M
Medicine (Baltimore); 2015 Aug; 94(31):e1270. PubMed ID: 26252293
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
[TBL] [Abstract][Full Text] [Related]
11. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report.
Omameuda T; Miyato H; Sata N; Lefor AK
Medicine (Baltimore); 2022 Nov; 101(47):e31993. PubMed ID: 36451467
[TBL] [Abstract][Full Text] [Related]
12. [Primary central nervous system methotrexate associated lymphoproliferative disorders in a patient with rheumatoid arthritis].
Uchida Y; Hokkoku K; Hatanaka Y; Kikuchi Y; Tashiro H; Sonoo M
Rinsho Shinkeigaku; 2018 Aug; 58(8):485-491. PubMed ID: 30068810
[TBL] [Abstract][Full Text] [Related]
13. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E
Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus infection and gene promoter hypermethylation in rheumatoid arthritis patients with methotrexate-associated B cell lymphoproliferative disorders.
Ejima-Yamada K; Oshiro Y; Okamura S; Fujisaki T; Mihashi Y; Tamura K; Fukushige T; Kojima M; Shibuya K; Takeshita M
Virchows Arch; 2017 Feb; 470(2):205-215. PubMed ID: 27864689
[TBL] [Abstract][Full Text] [Related]
15. Multi-modality imaging findings of methotrexate-related Epstein-Barr virus-associated hepatic tumor.
Fujita T; Tanabe M; Iida E; Okimoto T; Matsunaga N
Clin Imaging; 2013; 37(5):962-4. PubMed ID: 23849101
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate-associated Epstein-Barr virus mucocutaneous ulcer: A case report and review of literature.
Ravi PY; Sigamani E; Jeelani Y; Manipadam MT
Indian J Pathol Microbiol; 2018; 61(2):255-257. PubMed ID: 29676371
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
[TBL] [Abstract][Full Text] [Related]
18. Oral Methotrexate-related Lymphoproliferative Disease Presenting with Severe Osteonecrosis of the Jaw: A Case Report and Literature Review.
Furukawa S; Oobu K; Moriyama M; Kawano S; Sako S; Hayashida JN; Matsubara R; Ogata KI; Kiyoshima T; Nakamura S
Intern Med; 2018 Feb; 57(4):575-581. PubMed ID: 29225245
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J
J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
